4 quarters tracked · Beat rate 25% · Updated quarterly
| Period | Report Date | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | $5.36 | $5.65 | +5.5% | Beat |
| Q4 2025 | 2025-12-31 | $7.14 | $6.42 | -10.1% | Miss |
| Q3 2025 | 2025-09-30 | $5.43 | $5.27 | -2.9% | Miss |
| Q2 2025 | 2025-06-30 | $5.03 | $4.27 | -15.1% | Miss |
Earnings Beat Rate
Chemed Corp. has beaten analyst EPS estimates in 1 of 4 tracked quarters (25% beat rate). Data sourced from SEC filings and analyst consensus. View full AI analysis →